Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus Vaccination”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06534892
What this trial is testing

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 10,212
Large-scale testing (Phase 3)Not Yet RecruitingNCT07232706
What this trial is testing

Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination

Who this might be right for
RSV Immunization
Centre Hospitalier Annecy Genevois 1,000
Testing effectiveness (Phase 2)Study completedNCT06890429
What this trial is testing

Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults

Who this might be right for
Respiratory Synctial Virus Infections
Research Institute of Influenza, Russia 120
Post-approval studies (Phase 4)Study completedNCT00001903
What this trial is testing

Prevention of RSV Infections in Bone Marrow Transplant Recipients

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 120
Large-scale testing (Phase 3)Ended earlyNCT06252285
What this trial is testing

Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
RSV Immunisation
Sanofi Pasteur, a Sanofi Company 6,300
Not applicableLooking for participantsNCT06881953
What this trial is testing

Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France

Who this might be right for
RSV Infection
Assistance Publique - Hôpitaux de Paris 400
Large-scale testing (Phase 3)Ended earlyNCT06705140
What this trial is testing

A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
RSV Immunisation
Sanofi Pasteur, a Sanofi Company 947
Early research (Phase 1)Active Not RecruitingNCT07071558
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of Age

Who this might be right for
Respiratory Syncytial Virus Immunization
Sanofi 240
Large-scale testing (Phase 3)WithdrawnNCT05229068
What this trial is testing

Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline
Early research (Phase 1)Study completedNCT06850051
What this trial is testing

A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.

Who this might be right for
Healthy VolunteersInfluenza VaccinationRespiratory Syncytial Virus Vaccination+2 more
Sanofi 270
Large-scale testing (Phase 3)Study completedNCT05705440
What this trial is testing

A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 3,962
Not applicableNot Yet RecruitingNCT07279298
What this trial is testing

Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV

Who this might be right for
Respiratory Syncytial Virus InfectionsSevere Acute Respiratory InfectionBronchiolitis, Viral+1 more
Bogotá District Health Secretariat 1,097
Testing effectiveness (Phase 2)Looking for participantsNCT07050732
What this trial is testing

Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons

Who this might be right for
Respiratory Syncytial Virus (RSV)
Johns Hopkins University 170
Early research (Phase 1)Looking for participantsNCT06984094
What this trial is testing

First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

Who this might be right for
Respiratory Syncytial Virus VaccinationHuman Metapneumovirus VaccinationParainfluenza Vaccination
Clover Biopharmaceuticals AUS Pty 192
Not applicableActive Not RecruitingNCT07249320
What this trial is testing

Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants

Who this might be right for
Respiratory Syncytial Virus (RSV)
Pfizer 39,456
Large-scale testing (Phase 3)Looking for participantsNCT07203365
What this trial is testing

RSV Immunogenicity Study in the Elderly (RISE)

Who this might be right for
RSV Immunisation
Karin Karin Loré 65
Testing effectiveness (Phase 2)Study completedNCT05639894
What this trial is testing

Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 865
Testing effectiveness (Phase 2)Looking for participantsNCT06597916
What this trial is testing

RSV Vaccination in Immunocompromised Patients.

Who this might be right for
RSV Infection
Medical University of Vienna 200
Not applicableActive Not RecruitingNCT06824207
What this trial is testing

Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants

Who this might be right for
Respiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 2,400
Large-scale testing (Phase 3)Study completedNCT05437510
What this trial is testing

Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life

Who this might be right for
RSV ImmunizationHealthy Volunteer
Sanofi Pasteur, a Sanofi Company 8,057
Load More Results